LY246708 TARTRATE VS PLACEBO IN MILD TO MODERATE ALZHEIMER'S DISEASE

LY246708 酒石酸盐与安慰剂治疗轻至中度阿尔茨海默病的比较

• 批准号: 6278818
• 负责人: Mary Sano
• 金额: $ 2.3万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6278818
• 关键词: Alzheimer's disease; brain disorder chemotherapy; clinical research; dicarboxylate; dosage; drug screening /evaluation; human subject; human therapy evaluation; neuropharmacologic agent

This is a double blind study of an oral agent to be used in the treatment of Alzheimer's Disease. It is a multicenter, parallel group, placebo controlled study of safety and efficacy at doses of 25,50 or 75 mgm TID in patients with mild to moderate dementia.

这是一项对一种口服制剂的双盲研究，该制剂用于 阿尔茨海默病的治疗。它是一个多中心、平行的组织， 25、50和75剂量安慰剂的安全性和有效性对照研究 轻、中度痴呆患者的MGM TID。